The pandemic could end in 2022 — or we may suffer fresh setbacks. Operating with that huge global uncertainty, companies will record new triumphs and failures. This is what to look for next year across the corporate world in industries from pharma to technology.
Pharma
Trend to watch
Next year will be a new test for the pharmaceutical industry’s favourite four-letter acronym: mRNA, which stands for messenger ribonucleic acid. The Covid-19 vaccines proved the mRNA pioneers right: it is a rapid adaptable technology that can create highly effective vaccines.
In 2022, we will see early signs of how mRNA will perform beyond Covid, as Moderna, Pfizer, BioNTech and Sanofi will all publish data from trials using it for flu shots.
您已閱讀5%（729字），剩余95%（13146字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。